ArticleReports of biochemistry & molecular biology2025
Assessment of SF3B1 Expression as a Prognostic Marker for Neoadjuvant Chemotherapy Response in Stage III Triple-Negative Breast Cancer.
Desak Made Wihandani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.